CBT
AGN

Capital Bank & Trust’s Allergan plc AGN Stock Holding History

Capital Bank & Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-19
Closed -$3K – 726
2020
Q1 		$3K Buy
+19
New +$3.58K ﹤0.01% 626
2019
Q4 		– Sell
-123
Closed -$21K – 882
2019
Q3 		$21K Buy
123
+53
+76% +$8.63K ﹤0.01% 505
2019
Q2 		$12K Buy
+70
New +$9.69K ﹤0.01% 534
2018
Q1 		– Sell
-8
Closed -$1K – 720
2017
Q4 		$1K Sell
8
-119
-94% -$21.4K ﹤0.01% 692
2017
Q3 		$26K Buy
+127
New +$29.5K ﹤0.01% 428

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Capital Bank & Trust's AGN Position: Q2 2020 in Review

Capital Bank & Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 19 shares — an estimated $3K sold.

Capital Bank & Trust first reported a position in AGN in Q3 2017 and held it in 5 quarters. The position peaked at $26K in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capital Bank & Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 19 Allergan plc shares in Q2 2020, an estimated $3K.
  • Capital Bank & Trust first reported a position in Allergan plc in Q3 2017 and held it in 5 quarters.
  • Capital Bank & Trust's Allergan plc position peaked at $26K in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.